ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

165 hedge funds and large institutions have $930M invested in Esperion Therapeutics in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 36 closing their positions.

Holders
165
Holders Change
-7
Holders Change %
-4.07%
% of All Funds
3.64%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
32
Increased
58
Reduced
48
Closed
36
Calls
$9.76M
Puts
$14.2M
Net Calls
-$4.41M
Net Calls Change
-$15M

Top Buyers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$41.7M
2
PIM
2
Platinum Investment Management
Australia
$25.6M
3
BG
3
Bellevue Group
Switzerland
$159M
4
WA
4
Wasatch Advisors
Utah
$28.6M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$6.33M

Top Sellers

1
Nomura Holdings
1
Nomura Holdings
Japan
$7.08M
2
Man Group
2
Man Group
United Kingdom
$200K
3
Millennium Management
3
Millennium Management
New York
$2.69M
4
TCM
4
Tekla Capital Management
Massachusetts
$1.31M
5
Goldman Sachs
5
Goldman Sachs
New York
$7.47M
Name Holding Trade Value Shares
Change 		Shares
Change %
APM
26
Avidity Partners Management
Texas
$6.46M +$2.35M +74,600 +57%
HSBC Holdings
27
HSBC Holdings
United Kingdom
$6.46M +$316K +9,920 +5%
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$6.33M +$4.96M +157,446 +363%
Citadel Advisors
29
Citadel Advisors
Florida
$5.99M +$796K +25,242 +15%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$5.96M +$2.02M +64,091 +51%
BAMCO Inc
31
BAMCO Inc
New York
$5.94M – – –
Nuveen Asset Management
32
Nuveen Asset Management
Illinois
$5.81M +$642K +20,371 +12%
Charles Schwab
33
Charles Schwab
California
$5.79M -$1.21M -38,221 -17%
Barclays
34
Barclays
United Kingdom
$5.65M +$2.24M +71,195 +66%
Deutsche Bank
35
Deutsche Bank
Germany
$5.64M -$553K -17,541 -9%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$4.33M -$489K -15,513 -10%
JPMorgan Chase & Co
37
JPMorgan Chase & Co
New York
$4.28M +$1.08M +34,255 +34%
Invesco
38
Invesco
Georgia
$3.52M +$3.37M +106,957 +2,243%
SEI Investments
39
SEI Investments
Pennsylvania
$3.32M +$788K +24,987 +31%
PAMU
40
Pictet Asset Management (UK)
United Kingdom
$3.27M +$1.33M +42,100 +68%
PP
41
PDT Partners
New York
$3.27M +$1.08M +34,167 +49%
B
42
Bailard
California
$2.94M +$107K +3,400 +4%
MAP
43
Moody Aldrich Partners
Massachusetts
$2.8M -$1.12M -35,471 -29%
Adage Capital Partners
44
Adage Capital Partners
Massachusetts
$2.73M +$2.73M +86,484 New
UBS Group
45
UBS Group
Switzerland
$2.73M +$677K +21,458 +33%
NIP
46
Nicholas Investment Partners
California
$2.72M +$553K +17,548 +26%
Millennium Management
47
Millennium Management
New York
$2.69M -$5.45M -172,986 -67%
SCM
48
Sio Capital Management
New York
$2.54M +$755K +23,942 +42%
GH
49
GAM Holding
Switzerland
$2.23M -$545K -17,300 -20%
CAM
50
ClariVest Asset Management
California
$1.98M -$104K -3,313 -5%
1
2
3 4 5